chr4-56467653-C-CG
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_006947.4(SRP72):c.25dup(p.Val9GlyfsTer9) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000374 in 1,550,684 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000039 ( 0 hom. )
Consequence
SRP72
NM_006947.4 frameshift
NM_006947.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.46
Genes affected
SRP72 (HGNC:11303): (signal recognition particle 72) This gene encodes the 72 kDa subunit of the signal recognition particle (SRP), a ribonucleoprotein complex that mediates the targeting of secretory proteins to the endoplasmic reticulum (ER). The SRP complex consists of a 7S RNA and 6 protein subunits: SRP9, SRP14, SRP19, SRP54, SRP68, and SRP72, that are bound to the 7S RNA as monomers or heterodimers. SRP has at least 3 distinct functions that can be associated with the protein subunits: signal recognition, translational arrest, and ER membrane targeting by interaction with the docking protein. Mutations in this gene are associated with familial bone marrow failure. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAdExome4 at 55 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SRP72 | NM_006947.4 | c.25dup | p.Val9GlyfsTer9 | frameshift_variant | 1/19 | ENST00000642900.1 | NP_008878.3 | |
SRP72 | NM_001267722.2 | c.25dup | p.Val9GlyfsTer9 | frameshift_variant | 1/17 | NP_001254651.1 | ||
SRP72 | XM_024454192.2 | c.25dup | p.Val9GlyfsTer9 | frameshift_variant | 1/17 | XP_024309960.1 | ||
SRP72 | NR_151856.2 | n.44dup | non_coding_transcript_exon_variant | 1/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRP72 | ENST00000642900.1 | c.25dup | p.Val9GlyfsTer9 | frameshift_variant | 1/19 | NM_006947.4 | ENSP00000495128 | P1 | ||
SRP72 | ENST00000510663.6 | c.25dup | p.Val9GlyfsTer9 | frameshift_variant | 1/17 | 1 | ENSP00000424576 | |||
SRP72 | ENST00000504757.2 | c.25dup | p.Val9GlyfsTer9 | frameshift_variant | 1/5 | 2 | ENSP00000473576 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151404Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
3
AN:
151404
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000393 AC: 55AN: 1399280Hom.: 0 Cov.: 30 AF XY: 0.0000360 AC XY: 25AN XY: 694660
GnomAD4 exome
AF:
AC:
55
AN:
1399280
Hom.:
Cov.:
30
AF XY:
AC XY:
25
AN XY:
694660
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151404Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 73924
GnomAD4 genome
AF:
AC:
3
AN:
151404
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
73924
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 01, 2023 | This sequence change creates a premature translational stop signal (p.Val9Glyfs*9) in the SRP72 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in SRP72 cause disease. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with SRP72-related conditions. ClinVar contains an entry for this variant (Variation ID: 1723735). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 10, 2023 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene or region of a gene for which loss of function is not an established mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge - |
SRP72-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 05, 2024 | The SRP72 c.25dupG variant is predicted to result in a frameshift and premature protein termination (p.Val9Glyfs*9). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.012% of alleles in individuals of South Asian descent in gnomAD. Loss of function has not been conclusively established as a mechanism for SRP72-related disorders. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at